Health Care & Life Sciences » Pharmaceuticals | Ahn-Gook Pharmaceutical Co. Ltd.

Ahn-Gook Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
30,737
25,000
47,915
42,528
48,028
Total Accounts Receivable
42,080
53,604
63,542
57,061
62,548
Inventories
34,130
37,337
24,998
20,710
19,932
Other Current Assets
465
3,381
1,751
2,709
2,710
Total Current Assets
107,412
119,322
138,207
123,008
133,218
Net Property, Plant & Equipment
45,311
49,659
49,337
50,520
49,138
Total Investments and Advances
3,701
6,230
6,573
17,567
21,253
Intangible Assets
3,911
2,987
3,118
2,607
2,503
Other Assets
2,050
-
-
1,858
1,559
Total Assets
166,843
179,070
201,151
196,267
208,065
ST Debt & Current Portion LT Debt
11,263
10,851
10,125
22,823
19,916
Accounts Payable
9,537
15,602
16,047
17,243
17,850
Income Tax Payable
1,119
7,366
2,356
306
3,926
Other Current Liabilities
5,417
8,662
9,832
10,993
16,699
Total Current Liabilities
27,335
42,481
38,359
51,365
58,391
Long-Term Debt
785
3,215
16,052
1,772
746
Provision for Risks & Charges
8,700
10,888
12,779
11,636
11,452
Deferred Taxes
857
872
620
708
395
Other Liabilities
-
23
194
148
23
Total Liabilities
40,421
56,606
70,681
64,921
70,612
Common Equity (Total)
125,888
121,728
129,638
130,893
136,958
Total Shareholders' Equity
125,888
121,728
129,638
130,893
136,958
Total Equity
126,422
122,465
130,470
131,347
137,453
Liabilities & Shareholders' Equity
166,843
179,070
201,151
196,267
208,065
Accumulated Minority Interest
534
736
831
454
495

About Ahn-Gook Pharmaceutical Co.

View Profile
Address
613 Siheung-daero
Seoul SL 07445
Korea, Republic Of
Employees -
Website http://ahn-gook.com
Updated 09/14/2018
Ahn-Gook Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. Its products include health function food, medical supplement, quasi-drugs, over-the-counter drugs, ethical drugs, elatin solution and tablet, losastar tablet, suprafen tablet, and recommended products such as tobicom-S soft capsule, levotension tablet, and tobicomKid Q-10 chewable tablet. The company was founded by Noh Jong-Hyeong on September 16, 1955 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.